ResultsIQ

ResultsIQ › Latest results › Mold-Tek Technologies Limited

Mold-Tek Technologies Limited special call summary

NSE: MOLDTECH · BSE: 526263

Special call of 17 Jun 2025, summarised by AI from the filing.

Civil engineering order book about USD3.5 million as on 1st June, up from about USD2 million six to nine months ago.

Key takeaways

  1. Order book Civil engineering order book about USD3.5 million as on 1st June, up from about USD2 million six to nine months ago.
  2. MoUs signed MoUs with Interarch and Affordable Robotics open US building supply and MES entry into US and Europe, with commission on project value.
  3. Growth driver US civil work flow improved from March after election-related holds; BIW remains stagnant and SPM entry is targeted.
  4. Risk Tariff confusion on steel and steel buildings delayed US order take-off; clarity expected in a month or two.

Original filing on BSE

Mold-Tek Technologies Limited Q1 FY27 results

As filed: Revenue ₹59.5 cr (+80% year on year), EBITDA ₹11.9 cr (+300% year on year), PAT ₹9.0 cr (+300% year on year), EBITDA margin 19.9% (+1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹55.5 cr (+85% year on year), EBITDA ₹1.0 cr, PAT ₹2.3 cr, EBITDA margin 1.9% (+1,000 bps). Score 85 of 100, Above trend. Revenue growth was well above the company's own trend. EBITDA margin rose 1000 bps year on year. Other income 124% of PBT. Profit fell 41% from last quarter. Share price after the results: −9.4% in 29 days (Nifty 500: −0.1%).
  • Q3 FY26: Revenue ₹52.7 cr (+55% year on year), EBITDA ₹5.4 cr (+81% year on year), PAT ₹3.9 cr (+289% year on year), EBITDA margin 10.3% (+150 bps). Score 100 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 150 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −10.7% in 29 days (Nifty 500: −10.1%).
  • Q2 FY26: Revenue ₹40.0 cr (−7% year on year), EBITDA ₹4.0 cr (−69% year on year), PAT ₹3.0 cr (−63% year on year), EBITDA margin 10.0% (−1,000 bps). Score 20 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 1000 bps year on year. Other income 50% of PBT. Share price after the results: −9.3% in 28 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹33.0 cr (−15% year on year), EBITDA ₹1.0 cr (−88% year on year), PAT ₹1.0 cr (−80% year on year), EBITDA margin 3.0% (−1,000 bps). Score 10 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 1000 bps year on year. Other income 200% of PBT. Tax rate 0%. Share price after the results: +20.2% in 29 days (Nifty 500: +0.7%).
  • Q4 FY25: Revenue ₹30.0 cr (−29% year on year), EBITDA −₹3.0 cr (−133% year on year), PAT −₹2.0 cr (−133% year on year), EBITDA margin -10.0% (−1,000 bps). Score 7 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 1000 bps year on year. Revenue fell 12% from last quarter. Share price after the results: +14.5% in 29 days (Nifty 500: +3.3%).
  • Q3 FY25: Revenue ₹34.0 cr (−19% year on year), EBITDA ₹3.0 cr (−73% year on year), PAT ₹1.0 cr (−86% year on year), EBITDA margin 8.8% (−1,000 bps). Score 0 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 1000 bps year on year. Tax rate 0%. Revenue fell 21% from last quarter.
  • Q2 FY25: Revenue ₹43.0 cr (+8% year on year), EBITDA ₹13.0 cr (0% year on year), PAT ₹8.0 cr (0% year on year), EBITDA margin 30.2% (−227 bps). Score 32 of 100, Below trend. EBITDA margin fell 227 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Mold-Tek Technologies Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.